SG174540A1 - Agent for enhancing hypoglycemic activity - Google Patents

Agent for enhancing hypoglycemic activity Download PDF

Info

Publication number
SG174540A1
SG174540A1 SG2011069002A SG2011069002A SG174540A1 SG 174540 A1 SG174540 A1 SG 174540A1 SG 2011069002 A SG2011069002 A SG 2011069002A SG 2011069002 A SG2011069002 A SG 2011069002A SG 174540 A1 SG174540 A1 SG 174540A1
Authority
SG
Singapore
Prior art keywords
bacteria
acid bacteria
group
glucosidase inhibitor
bifidobacteria
Prior art date
Application number
SG2011069002A
Other languages
English (en)
Inventor
Yasuhiro Isa
Masaki Shimakawa
Hiroshi Ohno
Hideki Yamamura
Original Assignee
Biofermin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofermin Pharmaceutical Co Ltd filed Critical Biofermin Pharmaceutical Co Ltd
Publication of SG174540A1 publication Critical patent/SG174540A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/225—Faecalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/517—Bifidum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG2011069002A 2009-03-26 2010-03-25 Agent for enhancing hypoglycemic activity SG174540A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009077555 2009-03-26
PCT/JP2010/055238 WO2010110374A1 (ja) 2009-03-26 2010-03-25 血糖降下作用増強剤

Publications (1)

Publication Number Publication Date
SG174540A1 true SG174540A1 (en) 2011-10-28

Family

ID=42781065

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2011069002A SG174540A1 (en) 2009-03-26 2010-03-25 Agent for enhancing hypoglycemic activity
SG10201400931RA SG10201400931RA (en) 2009-03-26 2010-03-25 Agent for enhancing hypoglycemic activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201400931RA SG10201400931RA (en) 2009-03-26 2010-03-25 Agent for enhancing hypoglycemic activity

Country Status (5)

Country Link
US (1) US8889375B2 (OSRAM)
JP (2) JP5536504B2 (OSRAM)
MY (1) MY176503A (OSRAM)
SG (2) SG174540A1 (OSRAM)
WO (1) WO2010110374A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012011174A1 (ja) * 2010-07-22 2012-01-26 ビオフェルミン製薬株式会社 脂質代謝改善剤、脂質代謝改善作用増強剤、抗肥満剤及び抗肥満作用増強剤
JP5681533B2 (ja) * 2011-03-14 2015-03-11 ビオフェルミン製薬株式会社 消化管痛の予防又は軽減剤
JP6983407B2 (ja) * 2015-07-07 2021-12-17 東亜薬品工業株式会社 菌含有口腔内速崩壊性錠剤
KR101697260B1 (ko) * 2015-07-27 2017-01-17 고려대학교 산학협력단 보글리보즈를 유효성분으로 함유하는 비만 개선, 정장 또는 장내 균총 개선용 조성물
JP6637725B2 (ja) * 2015-10-28 2020-01-29 ビオフェルミン製薬株式会社 ウイルス感染症の予防及び／又は治療剤
JP6718512B2 (ja) 2016-09-02 2020-07-08 富士フイルム株式会社 家畜用飼料又は家畜用サプリメント、ラクトバチルス属細菌の増殖促進剤、並びにラクトバチルス属細菌の増殖促進方法
JP7235270B2 (ja) * 2018-02-09 2023-03-08 エースバイオプロダクト株式会社 血糖値上昇抑制剤及び同血糖値上昇抑制剤の製造方法
WO2020142698A1 (en) * 2019-01-05 2020-07-09 Foremost Technologies and Products, Inc. High pressure processing of foods and supplements
CN111748000B (zh) * 2019-03-29 2022-05-20 沈阳药科大学 3-脱氧-5-羟基-1-氨基碳糖类化合物及其用途
JP2020184909A (ja) * 2019-05-13 2020-11-19 学校法人帝京大学 血糖降下剤、及び、該血糖降下剤を含有する飲食品
CN112386612A (zh) * 2020-12-01 2021-02-23 贾卫国 一种用于预防糖尿病的益生菌生物制剂及其制备工艺
US20240174619A1 (en) * 2021-03-03 2024-05-30 Emergent Product Development Gaithersburg Inc. Valiolamine derivatives as glucosidase inhibitors
CN118620807B (zh) * 2024-08-15 2024-10-22 山东健源生物科技有限公司 一株具有减肥、降血糖作用的乳酸片球菌及其后生元和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194794A3 (en) 1985-03-08 1986-12-17 Takeda Chemical Industries, Ltd. Saccharide digestion inhibiting composition
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
JPH08298982A (ja) * 1995-05-02 1996-11-19 Aasu Giken:Kk 複合微生物製剤
JPH107577A (ja) 1996-06-17 1998-01-13 Yakult Honsha Co Ltd 血糖降下剤
JP2004113068A (ja) * 2002-09-25 2004-04-15 Sanwa Kosan Kk 腸内ビフィズス菌増殖促進剤
US7108869B2 (en) * 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
JP2004357505A (ja) * 2003-05-30 2004-12-24 Fancl Corp 胃腸疾患予防・軽減のための犬用サプリメント
JP4463525B2 (ja) * 2003-10-23 2010-05-19 ビオフェルミン製薬株式会社 減感作療法用剤
JP2006020581A (ja) * 2004-07-08 2006-01-26 Cdom:Kk ペット用食品及びその製造方法
JP2006020606A (ja) 2004-07-09 2006-01-26 Someya Hideo 肥満防止、改善のための健康食品用組成物
JP2006055116A (ja) * 2004-08-23 2006-03-02 Michiyo Miura α−グルコシダーゼ活性阻害食品
CA2655665A1 (en) 2006-05-26 2007-12-06 Nestec S.A. Methods of use and nutritional compositions of touchi extract
JP2007330124A (ja) 2006-06-13 2007-12-27 Kenko Tsusho Kk 肥満及び生活習慣病の防止・改善をする為の健康食品用組成物
JP4990297B2 (ja) * 2007-02-01 2012-08-01 株式会社Ｔｋバイオ研究所 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬
JP2008222701A (ja) * 2007-03-09 2008-09-25 Kangwon National Univ Industry Cooperation Foundation 肥満予防及び治療用発酵物、糖尿病予防用発酵物、肥満予防及び治療用発酵食品および糖尿病予防用食品

Also Published As

Publication number Publication date
JP5536504B2 (ja) 2014-07-02
JP5932878B2 (ja) 2016-06-08
US8889375B2 (en) 2014-11-18
US20120014923A1 (en) 2012-01-19
WO2010110374A1 (ja) 2010-09-30
MY176503A (en) 2020-08-12
JP2014141526A (ja) 2014-08-07
SG10201400931RA (en) 2014-07-30
JP2010248185A (ja) 2010-11-04

Similar Documents

Publication Publication Date Title
US8889375B2 (en) Hypoglycemic effect enhancer
JP4990297B2 (ja) ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬
KR101992537B1 (ko) 신규한 락토바실러스 사케이 및 이를 포함하는 조성물
KR102153080B1 (ko) 신규한 락토바실러스 살리바리우스 hem 1047 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
EP4049667A1 (en) Uremic toxin reducing agent
US20160213731A1 (en) Composition comprising fermented tea extracts for reducing lipid level
JP2017132763A (ja) 腸内細菌数抑制剤、食品、及び医薬品
KR101545551B1 (ko) 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
JP5769710B2 (ja) 脂質代謝改善剤、脂質代謝改善作用増強剤、抗肥満剤及び抗肥満作用増強剤
JP5681533B2 (ja) 消化管痛の予防又は軽減剤
KR102215592B1 (ko) 신규한 락토바실러스 퍼멘텀 hem 1036 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
JP5631721B2 (ja) 胃腸機能亢進剤
CN119215078A (zh) 副干酪乳酪杆菌Lc19在降低血糖中的应用
KR102215596B1 (ko) 신규한 스트렙토코커스 써모필러스 hem 14 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
KR102227383B1 (ko) 신규한 락토바실러스 파라카제이 hem 272 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
KR102215594B1 (ko) 신규한 락토바실러스 람노서스 hem 648 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
KR20120119555A (ko) 알파 글루코시다제 활성 저해용 조성물
KR102791846B1 (ko) 인체에서 체지방량을 감소시키기 위한 조성물 및 이의 용도
JP6402016B2 (ja) 神経機能改善剤
KR102593538B1 (ko) 박테로이데스 도레이 균주를 포함하는 간섬유증 예방 또는 치료용 약제학적 조성물
TWI797600B (zh) 用以提升腦組織能力之組合物及其用途
CN119331778A (zh) 一种用于辅助治疗糖尿病的乳酸菌组合物及复合乳酸菌益生菌剂和应用
KR100527104B1 (ko) 항당뇨 효능을 가지는 미생물을 함유한 당뇨병 예방 및치료용 조성물 및 이의 용도
KR20230153030A (ko) 신규한 비피도박테리움 비피덤 hem972 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
HK40078972A (en) Uremic toxin reducing agent